164 related articles for article (PubMed ID: 9758873)
1. [Association between the debrisoquine hydroxylase gene polymorphism and the genetic susceptibility of Parkinson's disease].
Tao E; Liu Z; Chen B; Pan X; Shao M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):281-3. PubMed ID: 9758873
[TBL] [Abstract][Full Text] [Related]
2. Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease.
Pang CP; Zhang J; Woo J; Chan D; Law LK; Tong SF; Kwok T; Kay R
Mov Disord; 1998 May; 13(3):529-32. PubMed ID: 9613747
[TBL] [Abstract][Full Text] [Related]
3. [Genetic polymorphisms of cytochrome P450 1A1 and susceptibility of early-onset Parkinson's disease].
Liu P; Liu Z; Shao M; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):283-5. PubMed ID: 11484167
[TBL] [Abstract][Full Text] [Related]
4. Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families.
Lucotte G; Turpin JC; Gérard N; Panserat S; Krishnamoorthy R
Am J Med Genet; 1996 Jul; 67(4):361-5. PubMed ID: 8837703
[TBL] [Abstract][Full Text] [Related]
5. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
[TBL] [Abstract][Full Text] [Related]
6. Association between the oxidative polymorphism and early onset of Parkinson's disease.
Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
[TBL] [Abstract][Full Text] [Related]
7. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.
Kurth MC; Kurth JH
Am J Med Genet; 1993 Oct; 48(3):166-8. PubMed ID: 8291573
[TBL] [Abstract][Full Text] [Related]
8. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.
Elbaz A; Levecque C; Clavel J; Vidal JS; Richard F; Amouyel P; Alpérovitch A; Chartier-Harlin MC; Tzourio C
Ann Neurol; 2004 Mar; 55(3):430-4. PubMed ID: 14991823
[TBL] [Abstract][Full Text] [Related]
9. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson's disease: a meta-analysis.
Christensen PM; Gøtzsche PC; Brøsen K
Pharmacogenetics; 1998 Dec; 8(6):473-9. PubMed ID: 9918130
[TBL] [Abstract][Full Text] [Related]
10. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
Wang J; Liu Z; Chen B
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822
[TBL] [Abstract][Full Text] [Related]
11. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
[TBL] [Abstract][Full Text] [Related]
12. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].
Wang J; Liu Z; Chen B
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):346-8. PubMed ID: 11798784
[TBL] [Abstract][Full Text] [Related]
13. [Genetic polymorphism and susceptibility to occupational chronic manganism: a case-control study].
Zheng Y; He F; Chan P; Pan Z; Wang Z; Pan J; Zhou X
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):78-80. PubMed ID: 11864457
[TBL] [Abstract][Full Text] [Related]
14. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females.
Lin JJ; Chen CH; Yueh KC; Chang CY; Lin SZ
Parkinsonism Relat Disord; 2006 Jan; 12(1):9-13. PubMed ID: 16337421
[TBL] [Abstract][Full Text] [Related]
15. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
16. Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
Nishimura M; Kaji R; Ohta M; Mizuta I; Kuno S
Mov Disord; 2002 Jul; 17(4):831-2. PubMed ID: 12210886
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphism of CYP-1A1, CYP2D6 and risks of chronic benzene poisoning].
Gu SY; Zhang ZB; Cao DZ; Wan JX; Gao XL; Jin XP; Xia ZL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 May; 24(5):266-9. PubMed ID: 16737584
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease.
Diederich N; Hilger C; Goetz CG; Keipes M; Hentges F; Vieregge P; Metz H
Ann Neurol; 1996 Sep; 40(3):463-5. PubMed ID: 8797539
[TBL] [Abstract][Full Text] [Related]
19. Debrisoquine hydroxylase and Parkinson's disease.
Kondo I; Kanazawa I
Adv Neurol; 1993; 60():338-42. PubMed ID: 8420147
[TBL] [Abstract][Full Text] [Related]
20. Examination of the MSX1 gene in patients with Parkinson's disease.
Deng H; Zhu SH; Le WD; Yang HR; Lv HW; Xu HB; Xie WJ; Jankovic J
Acta Neurol Scand; 2009 Dec; 120(6):442-4. PubMed ID: 19922584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
